Publications by authors named "Kurt Sizer"

Claim this Profile
T
The leprosy agents Mycobacterium lepromatosis and Mycobacterium leprae in Mexico.
Xiang Y Han, Kurt Clement Sizer, Jesús S Velarde-Félix, Luis O Frias-Castro, Francisco Vargas-Ocampo

Int J Dermatol· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of the leprosy agent Mycobacterium lepromatosis in Singapore.
Xiang Yang Han, Kurt Clement Sizer, Hiok-Hee Tan

J Drugs Dermatol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of safety concerns and regulatory changes on the usage of erythropoiesis-stimulating agents and RBC transfusions.
Saroj Vadhan-Raj, Xiao Zhou, Kurt Sizer, Lincy Lal, Xuemei Wang

Oncologist· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative sequence analysis of Mycobacterium leprae and the new leprosy-causing Mycobacterium lepromatosis.
Xiang Y Han, Kurt C Sizer, Erika J Thompson, Juma Kabanja, Jun Li

J Bacteriol· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new Mycobacterium species causing diffuse lepromatous leprosy.
Xiang Y Han, Yiel-Hea Seo, Kurt C Sizer, Taylor Schoberle, Gregory S May

Am J Clin Pathol· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Critically ill cancer patients are not consistently hypercoagulable after craniotomy.
Joseph L Nates, Natarajan Aravindan, Cheryl Hirsch-Ginsberg, Kurt C Sizer, Spencer Kee

Neurocrit Care· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heat shock protein 70, erythropoietin, and cancer.
Kurt C Sizer

J Clin Oncol· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I and pharmacologic study of PKI166, an epidermal growth factor receptor tyrosine kinase inhibitor, in patients with advanced solid malignancies.
Ronald Hoekstra, Herlinde Dumez, Ferry A L M Eskens, Ate van der Gaast, Andre S T Planting, Kurt C Sizer

Clin Cancer Res· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and safety of ICL670 in iron-loaded patients with thalassaemia: a randomised, double-blind, placebo-controlled, dose-escalation trial.
Eric Nisbet-Brown, Nancy F Olivieri, Patricia J Giardina, Robert W Grady, Ellis J Neufeld, Kurt C Sizer

Lancet· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis